missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Phospho-DR6 (Ser562) Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5104590
This item is not returnable.
View return policy
Description
Antibody detects endogenous levels of DR6 only when phosphorylated at Ser562.
DR6 is widely expressed in human tissues and cell lines. The ligand for DR6 has not been identified. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNF-R1 and Fas. Several novel death receptors including DR3, DR4, and DR5 were recently identified. A new death domain containing receptor in the TNFR family was cloned recently and termed DR6 for death receptor-6. Like TNF-R1, DR6 interacts with death domain containing adapter molecule TRADD. Overexpression of DR6 induces apoptosis and activates NF-kappa-B and JNK.
Specifications
| Phospho-DR6 (Ser562) | |
| Polyclonal | |
| Unconjugated | |
| TNFRSF21 | |
| AA959878; BM-018; CD358; Death receptor 6; Death receptor-6; DR6; MGC31965; R74815; sCD358; sDR6; soluble CD358; soluble DR6; TNF receptor superfamily member 21; TNFR-related death receptor 6; TNFR-related death receptor-6; Tnfrsf21; TR7; Tumor necrosis factor receptor superfamily member 21; tumor necrosis factor receptor superfamily, member 21; UNQ437/PRO868 | |
| Rabbit | |
| Sequential chromatography | |
| RUO | |
| 27242, 94185 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O75509, Q9EPU5 | |
| TNFRSF21 | |
| A synthesized peptide derived from human TNFRSF21(Accession O75509), corresponding to amino acid residues around phosphorylated Ser562. | |
| 100 μL | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction